latest updates in the treatment of lr-mds: commands and imerge trials
Published 1 year ago • 201 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
3:37
progress in the categorization and treatment of lr-mds
-
1:44
imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
2:51
analysis of the imerge trial: the disease-modifying potential of imetelstat in lr-mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:41
treatment of anemia in lr-mds: luspatercept and imetelstat
-
5:02
safety and efficacy of amlitelimab in ad: a phase iia rct, s. weidinger et al.
-
15:45
updates on the use of ropeginterferon in the treatment of mpns
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
1:13
the main treatment goals in lr-mds and how these differ from hr-mds
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
3:47
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:13
horizon scan of mds treatments
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
1:45
updates on the treatment of mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:02
update on treatments for high- and low-risk mds
-
7:05
state-of-the-art treatment regimens for lr-mds